Literature DB >> 19711446

Study of physico-chemical properties of novel highly sulfated, aromatic, mimetics of heparin and heparan sulfate.

Aiye Liang1, Jay N Thakkar, Umesh R Desai.   

Abstract

Heparin (H) and heparan sulfate (HS) play major roles in a number of biological processes. Yet, H/HS-based pharmaceutical agents are also associated with multiple adverse effects. This has led to the concept of designing noncarbohydrate, aromatic mimetics that modulate H/HS function. In this work, we study a library of synthetic, aromatic H/HS mimetics for their capillary electrophoretic profiles, the acid and base stability, and aqueous-organic partitioning property. The nonsugar H/HS mimetics exhibit electrophoretic properties similar to sulfated oligosaccharides suggesting that the mimetics can be rapidly and quantitatively analyzed. Stability studies show that the mimetics are essentially stable under neutral and basic conditions in a manner similar to the heparins, but are considerably unstable under acidic conditions in contrast to heparins. The measurement of partition coefficients show major differences within the sulfated mimetics as well as between the measured and calculated log P values. Understanding these physico-chemical properties is expected to have significant implications in the pharmaceutical development of this growing class of molecules. 2009 Wiley-Liss, Inc. and the American Pharmacists Association

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 19711446     DOI: 10.1002/jps.21908

Source DB:  PubMed          Journal:  J Pharm Sci        ISSN: 0022-3549            Impact factor:   3.534


  12 in total

Review 1.  Limitations of conventional anticoagulant therapy and the promises of non-heparin based conformational activators of antithrombin.

Authors:  Qudsia Rashid; Poonam Singh; Mohammad Abid; Mohamad Aman Jairajpuri
Journal:  J Thromb Thrombolysis       Date:  2012-08       Impact factor: 2.300

2.  Discovery of novel sulfonated small molecules that inhibit vascular tube formation.

Authors:  Karthik Raman; Rajesh Karuturi; Vimal P Swarup; Umesh R Desai; Balagurunathan Kuberan
Journal:  Bioorg Med Chem Lett       Date:  2012-04-16       Impact factor: 2.823

3.  Novel heparin mimetics reveal cooperativity between exosite 2 and sodium-binding site of thrombin.

Authors:  May H Abdel Aziz; Umesh R Desai
Journal:  Thromb Res       Date:  2018-03-17       Impact factor: 3.944

4.  Designing nonsaccharide, allosteric activators of antithrombin for accelerated inhibition of factor Xa.

Authors:  Rami A Al-Horani; Aiye Liang; Umesh R Desai
Journal:  J Med Chem       Date:  2011-08-12       Impact factor: 7.446

5.  Rational design of potent, small, synthetic allosteric inhibitors of thrombin.

Authors:  Preetpal Singh Sidhu; Aiye Liang; Akul Y Mehta; May H Abdel Aziz; Qibing Zhou; Umesh R Desai
Journal:  J Med Chem       Date:  2011-07-18       Impact factor: 7.446

6.  Sulfated, low molecular weight lignins inhibit a select group of heparin-binding serine proteases.

Authors:  Brian L Henry; Jay N Thakkar; Aiye Liang; Umesh R Desai
Journal:  Biochem Biophys Res Commun       Date:  2011-12-01       Impact factor: 3.575

7.  Identification of the site of binding of sulfated, low molecular weight lignins on thrombin.

Authors:  May H Abdel Aziz; Philip D Mosier; Umesh R Desai
Journal:  Biochem Biophys Res Commun       Date:  2011-08-27       Impact factor: 3.575

8.  Designing allosteric regulators of thrombin. Exosite 2 features multiple subsites that can be targeted by sulfated small molecules for inducing inhibition.

Authors:  Preetpal Singh Sidhu; May H Abdel Aziz; Aurijit Sarkar; Akul Y Mehta; Qibing Zhou; Umesh R Desai
Journal:  J Med Chem       Date:  2013-06-13       Impact factor: 7.446

9.  Dynamic affinity chromatography in the separation of sulfated lignins binding to thrombin.

Authors:  Aiye Liang; Jay N Thakkar; Michael Hindle; Umesh R Desai
Journal:  J Chromatogr B Analyt Technol Biomed Life Sci       Date:  2012-10-02       Impact factor: 3.205

10.  Polysulfated trehalose as a novel anticoagulant agent with dual mode of action.

Authors:  Qudsia Rashid; Mohammad Abid; Neha Gupta; Tarun Tyagi; Mohammad Z Ashraf; Mohamad Aman Jairajpuri
Journal:  Biomed Res Int       Date:  2015-03-17       Impact factor: 3.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.